Poly MVA
Poly MVA, and Reams Biological Theory, are two of the new, and very intriguing, ways of treating cancer. They approach cancer from a very different perspective than most other alternative treatment plans. While Dr. Garnett himself does not fully understand how Poly MVA works, his 30 years of testing different formulas has yielded a compound of metals, minerals, vitamins and amino acids that is showing excellent results ON TERMINAL PATIENTS. Because this product works on terminal patients, it is undoubtedly a great altervative to chemotherapy.
Poly-MVA is a uniquely formulated nutritional supplement containing a proprietary blend of Palladium and alpha-lipoic Acid (which we refer to as LAPd), Vitamins B1, B2 and B12, Formylmethionine, Acetyl Cystiene, and trace amounts of Molybdinum, Rhodium, and Ruthenium. It is designed to provide energy for the compromised body systems by changing the electrical potential of human cells, increasing the charge density of DNA within the cell.
If you have brain cancer or bone marrow cancer, pay close attention to this product, it has been shown to pass through the brain barrier and also get to Acute Lymphocytic Leukemia (ALL) bone marrow cancer.
One of the greatest physicians of our time, board-certified oncologist and anti-aging specialist James Forsythe, M.D., H.M.D., has finally been cleared of any wrongdoing and elevated to the level of protocol opinion leader after a long series of vicious attacks initiated by a rogue FDA agent. These attacks were then perpetuated by the U.S. Attorney's office in the form of a criminal indictment and an unrelenting investigation.
The appropriate use of natural hormone replacement therapy for wellness, and wonderful supplements such as Poly MVA (palladium lipoic complex) for cancer patients, have been vindicated as well.
The FDA agent who told Dr. Forsythe's cancer patients that the Poly MVA they were taking was "poison" must now swallow the poison of knowing that his attack on those patients' health freedom has ended in complete and utter failure?a great victory for cancer patients everywhere.
Appropriate use of Poly MVA for cancer patients has prevailed against a vicious attack prompted by its own success. The FDA began this particular attack in 2005 after concluding that the reported remission rates among those patients in the Poly MVA study were "too good to be true."